AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationLeukemia, Myeloid, AcuteGraft vs Host DiseaseTransplantation ConditioningLeukemia, MyeloidTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationLeukemiaRemission InductionTransplantation ChimeraStem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTreatment OutcomeBone Marrow TransplantationGraft vs Leukemia EffectRecurrenceBusulfanVidarabineTissue DonorsMyeloablative AgonistsMyelodysplastic SyndromesAcute DiseaseGraft vs Tumor EffectCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingGraft SurvivalDisease-Free SurvivalHematopoietic Stem CellsLymphocyte TransfusionSurvival AnalysisRetrospective StudiesNeoplasm, ResidualSurvival RateImmunosuppressive AgentsCombined Modality TherapyMultiple Myelomafms-Like Tyrosine Kinase 3Salvage TherapySiblingsAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationCord Blood Stem Cell TransplantationCytomegalovirus InfectionsMinor Histocompatibility AntigensPrognosisLymphocyte DepletionAntilymphocyte SerumLiver TransplantationAntineoplastic AgentsFusion Proteins, bcr-ablHistocompatibilityBenzamidesVirus ActivationTime FactorsCytogenetic AnalysisMelphalanLeukemia, Lymphocytic, Chronic, B-CellAntigens, CD34CyclophosphamideBlast CrisisPyrimidinesGene Expression Regulation, LeukemicHepatic Veno-Occlusive DiseaseChimerismPiperazinesLeukemia, Myeloid, Accelerated PhaseT-LymphocytesFollow-Up StudiesHematopoietic Stem Cell MobilizationBone MarrowPrimary MyelofibrosisMesenchymal Stem Cell TransplantationCytomegalovirusAnemia, AplasticHLA AntigensLeukemia, Myelomonocytic, AcuteHematologic DiseasesCell TransplantationCell DifferentiationFlow CytometryGranulocyte Colony-Stimulating FactorKidney TransplantationEmbryonic Stem CellsAntibodies, NeoplasmDaunorubicinBone Marrow CellsImmunophenotypingEtoposideImmunocompromised HostIdarubicinImmunosuppressionTransplantation ImmunologyLymphoproliferative DisordersFatal OutcomeRoseolovirus InfectionsHodgkin Disease

No FAQ available that match "patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced intensity patients with acute myeloid leukemia allogeneic stem cell transplantation"